Nuvo Group USA, Inc. and affiliated entities filed for Chapter 11 protection on August 22, 2024 in Delaware (Case No. 24-11880) following a de-SPAC merger with LAMF Global Ventures Corp. that left the company with limited cash (~$400K at closing; $28,692 at petition) and unable to secure additional financing. Nuvo develops and markets INVU, an FDA-cleared remote pregnancy monitoring platform using wearable sensor bands and cloud-based AI/ML analytics. The company reported 2023 revenue of ~$176K against cost of revenues of ~$191K, with ~$100M in cumulative funding raised but a capital-intensive product development cycle that exceeded available liquidity. At filing, Nuvo carried approximately $12.8 million in secured bridge financing notes (15% interest) and an estimated $11 million in unsecured trade debt. A $10 million DIP term loan funded by Nuvo Investors DIP LLC provided interim liquidity to pursue a Section 363 sale process. The court approved a bidding procedures order in October 2024, and Nuvo Int'l Group Inc. (backed by Kips Bay Select LP) was selected as the winning bidder on November 22, 2024. The sale order was entered on December 12, 2024, and the transaction closed on December 13, 2024, with total consideration of approximately $10.5 million (including a $7.7 million DIP credit bid, $2.5 million cash, and assumption of postpetition payables). As of February 2026, no plan or confirmation order has surfaced; the case remains in a post-sale administrative phase.